Recent Updates
Recently added Catalysts
BDX Positive Sentiment Score: 70/100

BD To Host Virtual 2025 Annual Meeting of Shareholders BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host its virtual 2025...

Key Takeaway: BD (Becton, Dickinson and Company) announced that it will host its virtual 2025 Annual Meeting of Shareholders on January 28, 2025, at 1:00 p.m. ET. Shareholders as of December 9, 2024, will have the opportunity to attend, vote, and ask questions during the meeting, with guests permitted to listen only. A replay of the meeting will be available on BD's website for one year after the event. BD is recognized as a leading global medical technology company, dedicated to improving health outcomes through innovative technologies and solutions.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is committed to advancing healthcare through innovation.
  • The virtual meeting allows increased shareholder participation.
  • The company emphasizes its global presence and capabilities.

Full Press Release Details

FRANKLIN LAKES, N.J. , Jan. 7, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it will host its virtual 2025 Annual Meeting of Shareholders (the "Annual Meeting") on Tuesday, January 28, 2025 , at 1:00 p.m. (ET) .
As described in the proxy materials for the Annual Meeting previously distributed, shareholders as of the close of business on December 9, 2024 , or their duly authorized proxies, will be able to attend and participate in the Annual Meeting, vote their shares and ask questions by visiting https://meetnow.global/M5X7D4A . Guests may also access the Annual Meeting but in listen-only mode. No control number is required for guests.
A replay of the webcast will be available shortly after the Annual Meeting on the BD website at investors.bd.com for approximately one year from the date of the Annual Meeting.
About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD , please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ , X (formerly Twitter) @BDandCo or Instagram @becton_dickinson .
Contacts:
Media : Investors :
Troy Kirkpatrick Adam Reiffe
VP, Public Relations Sr. Director, Investor Relations
858.617.2361 201.847.6927
[email protected] [email protected]
SOURCE BD (Becton, Dickinson and Company)

21 %

Frequently Asked Questions

When is the BD Annual Meeting scheduled?

The BD Annual Meeting will take place on January 28, 2025, at 1:00 p.m. ET.

How can shareholders participate in the Annual Meeting?

Shareholders can attend and participate by visiting https://meetnow.global/M5X7D4A.

Can guests attend the BD Annual Meeting?

Yes, guests can attend in listen-only mode without a control number.

Where can I find the webcast replay?

The webcast replay will be available on the BD website for about one year.

Last updated: Jan 7, 2025